MetaCap

Baird Medical Investment (BDMD) vs PAVmed (PAVM)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

Baird Medical Investment (BDMD) has outperformed PAVmed (PAVM) over the past year, losing 50.3% versus a loss of 81.1%. Baird Medical Investment is the larger company by market cap ($25.0 million vs $21.5 million), about 1.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BDMD-50.31%PAVM-81.12%
+126%+18%-91%
Oct 8, 20251 yearOct 8, 2026
BDMD-91.90%PAVM-99.80%
+24%-41%-106%
Dec 13, 20215 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BDMD versus PAVM key metrics
MetricBDMDPAVM
Share price$0.78$2.69
Market cap$25.05M$21.51M
1-day change-1.27%0.00%
YTD return-41.91%-59.43%
1-year return-50.31%-81.12%
5-year return—-99.90%
Forward P/E5.57—
EPS (TTM)$-0.55$-14.20
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$3.70$28.44
52-week low$0.661$2.60
Distance from 52-week high-78.92%-90.54%
Analyst consensusnonenone
Avg. price target upside+412.82%+1256.88%
Average volume53.21K30.34K
Shares outstanding32.11M8.00M
Employees14641
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • BDMD has outperformed PAVM by 30.8 percentage points over the past year.

About Baird Medical Investment

BDMD stock →

Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; and long and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, and uterine fibroids, as well as soft tissue ablation.

Health Care · Medical/Dental Instruments · 146 employees

About PAVmed

PAVM stock →

PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States.

Health Care · Medical/Dental Instruments · 41 employees

BDMD vs PAVM FAQ

Which is bigger, Baird Medical Investment or PAVmed?

Baird Medical Investment (BDMD) is larger, with a market capitalization of $25.05M compared with $21.51M for PAVmed (PAVM).

Which stock has performed better over the past year, BDMD or PAVM?

BDMD returned -50.31% over the past 12 months, compared with -81.12% for PAVM (price return, excluding dividends). Past performance does not predict future results.

Are Baird Medical Investment and PAVmed in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons